Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elena Shagisultanova
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Related publications
21-Gene Recurrence Score Decreases Receipt of Chemotherapy in ER+ Early-Stage Breast Cancer: An Analysis of the NCDB 2010–2013
Breast Cancer Research and Treatment
Cancer Research
Oncology
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Distribution Patterns of 21-Gene Recurrence Score in 980 Chinese Estrogen Receptor-Positive, HER2-negative Early Breast Cancer Patients
Oncotarget
Oncology
Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! For Women With Node-Negative, ER-positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Breast Cancer Research and Treatment
Cancer Research
Oncology
Lymph Node Involvement: Positive About the Role of the Recurrence Score in Estrogen-Driven Breast Cancer?
Cancer
Cancer Research
Oncology
Evaluating the 21-Gene Assay Recurrence Score® as a Predictor of Clinical Response to 24 Weeks of Neoadjuvant Exemestane in Estrogen Receptor-Positive Breast Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Randomised Trial: Survival Benefit and Safety of Adjuvant Dose-Dense Chemotherapy for Node-Positive Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age
Advances in Therapy
Medicine
Pharmacology